VitaDAO and Molecule AG partner with Apollo Health Ventures to build the longevity biotech & Web3 ecosystem Kumar Jeetendra | February 21, 2022 Feb. 21, 2022, Switzerland – Life Science Newswire – Molecule, a biotech IP Web3 marketplace, announces a tripartite partnership with Apollo Health Ventures, a leading longevity-focused venture capital fund, and VitaDAO, a decentralized autonomous organization funding early-stage longevity biotech (“LongBio”) R&D. VitaDAO and Molecule collaboratively source geroscience assets and finance R&D at universities, institutes, and …
